Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway

Aida Maddahi1, Lars Edvinsson

  • 1Department of Internal Medicine, Institute of Clinical Sciences, Lund University, Sweden. lars.edvinsson@med.lu.se

Abstract

Insights

Inhibition of the MEK/ERK pathway with U0126 following cerebral ischemia significantly reduced infarct size and inflammation. Combined receptor blockade also decreased brain damage, highlighting the MEK/ERK pathway

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pathophysiology

Background:

  • Middle cerebral artery (MCA) occlusion causes cerebral ischemia, leading to inflammation and receptor activation.
  • The mitogen-activated protein kinase (MAPK) pathway is activated, reducing cerebral blood flow and increasing inflammatory mediators.

Purpose of the Study:

  • To investigate the effect of MEK1/2 inhibitor (U0126) on cerebrovascular inflammation.
  • To determine if combined angiotensin and endothelin receptor blockade reduces infarct size and improves neurological scores.

Main Methods:

  • Rats underwent middle cerebral artery occlusion (MCAO) for 2 hours, followed by 48 hours of reperfusion.
  • Animals received U0126 at 0, 6, or 12 hours post-occlusion, or a combination of Candesartan and ZD1611.
  • Immunohistochemistry analyzed inflammatory markers (TNF-α, IL-1β, IL-6, iNOS) and phosphorylated ERK1/2.

Main Results:

  • U0126 administered at 0 or 6 hours post-MCAO reduced infarct volume and normalized phosphorylated ERK1/2 levels.
  • Treatment with U0126 prevented the elevation of inflammatory markers.
  • Combined receptor antagonists reduced infarct volume but had minimal effect on inflammatory marker expression.

Conclusions:

  • Microvascular expression of TNF-α, IL-1β, IL-6, and iNOS increases after focal ischemia.
  • This inflammatory response is transcriptionally regulated by the MEK/ERK pathway.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...